• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?《低风险大麻使用指南》(LRCUG)的建议:加拿大的大麻使用者遵循情况如何?
Prev Med Rep. 2020 Aug 26;20:101187. doi: 10.1016/j.pmedr.2020.101187. eCollection 2020 Dec.
2
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations.低风险大麻使用指南:证据与建议的全面更新
Am J Public Health. 2017 Aug;107(8):e1-e12. doi: 10.2105/AJPH.2017.303818. Epub 2017 Jun 23.
3
Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update.降低非医疗用大麻使用健康危害的低风险大麻使用指南(LRCUG):全面的证据和建议更新。
Int J Drug Policy. 2022 Jan;99:103381. doi: 10.1016/j.drugpo.2021.103381. Epub 2021 Aug 28.
4
The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.低风险大麻使用指南(LRCUG):新西兰现成的针对大麻的预防工具。
Public Health Pract (Oxf). 2020 Oct 29;1:100046. doi: 10.1016/j.puhip.2020.100046. eCollection 2020 Nov.
5
Introducing the evidence-based population health tool of the Lower-Risk Cannabis Use Guidelines to Brazil.向巴西介绍基于证据的低风险大麻使用指南这一人口健康工具。
Braz J Psychiatry. 2019 Nov-Dec;41(6):550-555. doi: 10.1590/1516-4446-2018-0239.
6
Lower Risk Cannabis use Guidelines for Canada (LRCUG): a narrative review of evidence and recommendations.加拿大低风险大麻使用指南(LRCUG):证据和建议的叙述性综述。
Can J Public Health. 2011 Sep-Oct;102(5):324-7. doi: 10.1007/BF03404169.
7
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.加拿大合法化前后选择的大麻使用和供应指标概述。
Subst Abuse Treat Prev Policy. 2021 Oct 7;16(1):77. doi: 10.1186/s13011-021-00405-7.
8
Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.大麻使用者的类型学及其与公共卫生相关的特征:基于全国代表性加拿大成人调查数据的潜在类别分析。
Int J Methods Psychiatr Res. 2010 Jun;19(2):110-24. doi: 10.1002/mpr.307.
9
The impact of cannabis legalization for recreational purposes on youth: A narrative review of the Canadian experience.娱乐用大麻合法化对青少年的影响:对加拿大经验的叙述性综述。
Front Psychiatry. 2022 Sep 23;13:984485. doi: 10.3389/fpsyt.2022.984485. eCollection 2022.
10
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.

引用本文的文献

1
Lower-risk substance use guidelines accessible by youth.青少年可获取的低风险物质使用指南。
Subst Abuse Treat Prev Policy. 2023 Feb 13;18(1):10. doi: 10.1186/s13011-023-00516-3.
2
The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.低风险大麻使用指南(LRCUG):新西兰现成的针对大麻的预防工具。
Public Health Pract (Oxf). 2020 Oct 29;1:100046. doi: 10.1016/j.puhip.2020.100046. eCollection 2020 Nov.
3
Use of a Novel EEG-Based Objective Test, the Cognalyzer, in Quantifying the Strength and Determining the Action Time of Cannabis Psychoactive Effects and Factors that May Influence Them Within an Observational Study Framework.在一项观察性研究框架内,使用基于脑电图的新型客观测试工具Cognalyzer来量化大麻精神活性作用的强度、确定其作用时间以及可能影响这些作用的因素。
Neurol Ther. 2022 Mar;11(1):51-72. doi: 10.1007/s40120-021-00293-w. Epub 2021 Nov 2.
4
An overview of select cannabis use and supply indicators pre- and post-legalization in Canada.加拿大合法化前后选择的大麻使用和供应指标概述。
Subst Abuse Treat Prev Policy. 2021 Oct 7;16(1):77. doi: 10.1186/s13011-021-00405-7.
5
Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients.血清蛋白质组学分析男性大麻使用障碍患者。
Molecules. 2021 Sep 1;26(17):5311. doi: 10.3390/molecules26175311.
6
Prevalence of Medical Cannabis Use and Associated Health Conditions Documented in Electronic Health Records Among Primary Care Patients in Washington State.在华盛顿州的初级保健患者的电子健康记录中记录的医用大麻使用和相关健康状况的流行率。
JAMA Netw Open. 2021 May 3;4(5):e219375. doi: 10.1001/jamanetworkopen.2021.9375.

本文引用的文献

1
Evaluating the impacts of cannabis legalization: The International Cannabis Policy Study.评估大麻合法化的影响:国际大麻政策研究
Int J Drug Policy. 2020 Feb 26;77:102698. doi: 10.1016/j.drugpo.2020.102698.
2
Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates.大麻合法化时代美国青少年的大麻使用情况:使用模式变化、共病和健康相关性的综述。
Int Rev Psychiatry. 2020 May;32(3):221-234. doi: 10.1080/09540261.2020.1713056. Epub 2020 Feb 6.
3
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.合法与非法娱乐用大麻市场中大麻使用的流行情况及形式。
Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9.
4
Lower-Risk Cannabis Use Guidelines: Will Users Listen?低风险大麻使用指南:使用者会听从吗?
Am J Public Health. 2020 Jan;110(1):71-72. doi: 10.2105/AJPH.2019.305420.
5
The Prevalence of Vaping and Smoking as Modes of Delivery for Nicotine and Cannabis among Youth in Canada, England and the United States.加拿大、英国和美国青少年中尼古丁和大麻的吸食和吸烟方式的流行率。
Int J Environ Res Public Health. 2019 Oct 25;16(21):4111. doi: 10.3390/ijerph16214111.
6
Public health implications of legalising the production and sale of cannabis for medicinal and recreational use.将大麻的生产和销售合法化用于医疗和娱乐用途对公共卫生的影响。
Lancet. 2019 Oct 26;394(10208):1580-1590. doi: 10.1016/S0140-6736(19)31789-1. Epub 2019 Oct 23.
7
Communicating THC levels and 'dose' to consumers: Implications for product labelling and packaging of cannabis products in regulated markets.向消费者传达 THC 水平和“剂量”:对受监管市场中大麻产品的产品标签和包装的影响。
Int J Drug Policy. 2021 May;91:102509. doi: 10.1016/j.drugpo.2019.07.004. Epub 2019 Jul 25.
8
Marijuana Use in Pregnancy: A Review.孕期大麻使用:综述。
Obstet Gynecol Surv. 2019 Jul;74(7):415-428. doi: 10.1097/OGX.0000000000000685.
9
Analysis of trends in the prevalence of cannabis use and related metrics in Canada.加拿大大麻使用流行趋势及相关指标分析。
Health Rep. 2019 Jun 19;30(6):3-13. doi: 10.25318/82-003-x201900600001-eng.
10
Youth and Adult Arrests for Cannabis Possession After Decriminalization and Legalization of Cannabis.大麻非刑罪化和合法化后青少年及成年人因持有大麻被捕的情况。
JAMA Pediatr. 2019 Aug 1;173(8):763-769. doi: 10.1001/jamapediatrics.2019.1539.

《低风险大麻使用指南》(LRCUG)的建议:加拿大的大麻使用者遵循情况如何?

The Lower-Risk Cannabis Use Guidelines' (LRCUG) recommendations: How are Canadian cannabis users complying?

作者信息

Lee Chae-Rim, Lee Angelica, Goodman Samantha, Hammond David, Fischer Benedikt

机构信息

Centre for Applied Research in Mental Health & Addiction, Faculty of Health Sciences, Simon Fraser University, Vancouver, BC, Canada.

School of Public Health & Health Systems, University of Waterloo, Waterloo, ON, Canada.

出版信息

Prev Med Rep. 2020 Aug 26;20:101187. doi: 10.1016/j.pmedr.2020.101187. eCollection 2020 Dec.

DOI:10.1016/j.pmedr.2020.101187
PMID:33083205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7554648/
Abstract

Canada, alongside other jurisdictions, implemented non-medical cannabis legalization in 2018, partly towards improving public health. Evidence-based 'Lower-Risk Cannabis Use Guidelines' (LRCUG), including recommendations for cannabis users on how to decrease risk-behaviors for harms, have been developed and widely disseminated in Canada since 2017. However, knowledge on users' compliance with the LRCUG is limited. We identified four major Canadian (three national, one provincial) population surveys presenting key data on cannabis-related behaviors: the National Cannabis Survey, Canadian Cannabis Survey, Canadian Tobacco, Alcohol & Drugs Survey, and CAMH Monitor. We scanned each survey for indicator data mapping onto either of the LRCUG's recommendations for the years 2017 to 2019. Relevant indicator data, albeit with varying operationalizations, were found for six of the ten LRCUG's recommendation clusters in at least some of the surveys, and were extracted and summarized. For results, substantial -- but declining -- majorities of users consumed cannabis by smoking, yet with shifts towards other use modes. Between one- to two-in-five users engaged in the risk-behaviors of using high-potency cannabis products, frequent cannabis use and cannabis-impaired driving, respectively. A small proportion of pregnant or breastfeeding women continued cannabis use during the study period. The data identified found suggested a heterogeneous picture regarding cannabis users' compliance with the LRCUG's recommendations. Non-compliance is highest for recommendations regarding modes-of-use, and applies to minorities of users for other risks factors. These sub-groups are at elevated risk for acute (e.g., accidents) or long-term (e.g., dependence) cannabis-related harms contributing to the public health burden. Appropriate targeted interventions in these areas require improvement.

摘要

2018年,加拿大与其他司法管辖区一道实施了非医用大麻合法化,部分目的是改善公众健康。自2017年以来,加拿大已经制定并广泛传播了基于证据的《低风险大麻使用指南》(LRCUG),其中包括针对大麻使用者如何减少伤害风险行为的建议。然而,关于使用者对LRCUG的遵守情况的了解有限。我们确定了四项主要的加拿大(三项全国性、一项省级)人口调查,这些调查提供了与大麻相关行为的关键数据:全国大麻调查、加拿大大麻调查、加拿大烟草、酒精和药物调查以及成瘾与心理健康中心监测。我们在每项调查中搜索了2017年至2019年期间与LRCUG的任何一项建议相对应的指标数据。尽管操作方式各不相同,但在至少一些调查中,在LRCUG的十个建议类别中的六个类别中发现了相关指标数据,并进行了提取和总结。结果显示,相当多但比例在下降的大多数使用者通过吸烟使用大麻,但使用方式正转向其他模式。分别有五分之一到五分之二的使用者从事使用高效力大麻产品、频繁使用大麻和大麻影响下驾驶等风险行为。在研究期间,一小部分孕妇或哺乳期妇女继续使用大麻。所发现的数据表明,大麻使用者对LRCUG建议的遵守情况呈现出不同的情况。关于使用方式的建议的不遵守情况最高,而对于其他风险因素,不遵守情况适用于少数使用者。这些亚组面临急性(如事故)或长期(如依赖)大麻相关伤害的风险升高,这增加了公共卫生负担。在这些领域进行适当的有针对性的干预需要改进。